The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kessels, H. W. H. G.
Right arrow Articles by Schumacher, T. N. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kessels, H. W. H. G.
Right arrow Articles by Schumacher, T. N. M.
The Journal of Immunology, 2006, 177: 976-982.
Copyright © 2006 by The American Association of Immunologists

Generation of T Cell Help through a MHC Class I-Restricted TCR1

Helmut W. H. G. Kessels2,3,*, Koen Schepers2,*, Marly D. van den Boom*, David J. Topham{dagger} and Ton N. M. Schumacher4,*

* Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; and {dagger} Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, Aab Institute of Biomedical Sciences, University of Rochester, Rochester, NY 14642

CD4+ T cells that are activated by a MHC class II/peptide encounter can induce maturation of APCs and promote cytotoxic CD8+ T cell responses. Unfortunately, the number of well-defined tumor-specific CD4+ T cell epitopes that can be exploited for adoptive immunotherapy is limited. To determine whether Th cell responses can be generated by redirecting CD4+ T cells to MHC class I ligands, we have introduced MHC class I-restricted TCRs into postthymic murine CD4+ T cells and examined CD4+ T cell activation and helper function in vitro and in vivo. These experiments indicate that Ag-specific CD4+ T cell help can be induced by the engagement of MHC class I-restricted TCRs in peripheral CD4+ T cells but that it is highly dependent on the coreceptor function of the CD8beta-chain. The ability to generate Th cell immunity by infusion of MHC class I-restricted Th cells may prove useful for the induction of tumor-specific T cell immunity in cases where MHC class II-associated epitopes are lacking.




This article has been cited by other articles:


Home page
J. Immunol.Home page
B. Pang, J. Neijssen, X. Qiao, L. Janssen, H. Janssen, C. Lippuner, and J. Neefjes
Direct Antigen Presentation and Gap Junction Mediated Cross-Presentation during Apoptosis
J. Immunol., July 15, 2009; 183(2): 1083 - 1090.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. T. van der Veken, M. Coccoris, E. Swart, J. H. F. Falkenburg, T. N. Schumacher, and M. H. M. Heemskerk
{alpha}{beta} T Cell Receptor Transfer to {gamma}{delta} T Cells Generates Functional Effector Cells without Mixed TCR Dimers In Vivo
J. Immunol., January 1, 2009; 182(1): 164 - 170.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. de Witte, A. Jorritsma, A. Kaiser, M. D. van den Boom, M. Dokter, G. M. Bendle, J. B. A. G. Haanen, and T. N. M. Schumacher
Requirements for Effective Antitumor Responses of TCR Transduced T Cells
J. Immunol., October 1, 2008; 181(7): 5128 - 5136.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
K. Schepers, E. Swart, J. W.J. van Heijst, C. Gerlach, M. Castrucci, D. Sie, M. Heimerikx, A. Velds, R. M. Kerkhoven, R. Arens, et al.
Dissecting T cell lineage relationships by cellular barcoding
J. Exp. Med., September 29, 2008; 205(10): 2309 - 2318.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. de Witte, G. M. Bendle, M. D. van den Boom, M. Coccoris, T. D. Schell, S. S. Tevethia, H. van Tinteren, E. M. Mesman, J.-Y. Song, and T. N. M. Schumacher
TCR Gene Therapy of Spontaneous Prostate Carcinoma Requires In Vivo T Cell Activation
J. Immunol., August 15, 2008; 181(4): 2563 - 2571.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Chhabra, L. Yang, P. Wang, B. Comin-Anduix, R. Das, N. G. Chakraborty, S. Ray, S. Mehrotra, H. Yang, C. L. Hardee, et al.
CD4+CD25- T Cells Transduced to Express MHC Class I-Restricted Epitope-Specific TCR Synthesize Th1 Cytokines and Exhibit MHC Class I-Restricted Cytolytic Effector Function in a Human Melanoma Model
J. Immunol., July 15, 2008; 181(2): 1063 - 1070.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Coccoris, E. Swart, M. A. de Witte, J. W. J. van Heijst, J. B. A. G. Haanen, K. Schepers, and T. N. M. Schumacher
Long-Term Functionality of TCR-Transduced T Cells In Vivo
J. Immunol., May 15, 2008; 180(10): 6536 - 6543.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. F. Robbins, Y. F. Li, M. El-Gamil, Y. Zhao, J. A. Wargo, Z. Zheng, H. Xu, R. A. Morgan, S. A. Feldman, L. A. Johnson, et al.
Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions
J. Immunol., May 1, 2008; 180(9): 6116 - 6131.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Jorritsma, R. Gomez-Eerland, M. Dokter, W. van de Kasteele, Y. M. Zoet, I. I. N. Doxiadis, N. Rufer, P. Romero, R. A. Morgan, T. N. M. Schumacher, et al.
Selecting highly affine and well-expressed TCRs for gene therapy of melanoma
Blood, November 15, 2007; 110(10): 3564 - 3572.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.